Left Atrial Appendage Exclusion System for Evaluation of POAF

AtriClip® Left Atrial Appendage Exclusion Concomitant to Structural Heart Procedures (ATLAS)

January 17, 2018

  • Clinical Trial Information

    Trial Contact: Tinetti, Meghan

    Trial Phone: 321.841.3682

  • IRB No: 17.005.01

    Protocol Abbrev: ATLAS

    Principal Investigator: Steven J. Hoff, MD

    Sub Investigators: Bott, Jeffrey Norman MD; Ball, Stephen

    Phase: Device: Significant Risk

    Age Group: Adult

    Secondary Protocol No: CP2015-2

    Treatment: Device: AtriClip

    Applicable Disease Sites: Coronary Artery Disease, Valvular Disease

    Therapies Involved: Surgery

    ClinicalTrials.gov ID: NCT02701062

  • Objective

    Compare impact of Post-Operative Atrial Fibrillation (POAF)among 2 Randomized arms. Patients with POAF and surgical LAA closrue versus patients with POAF and no surgical LAA closure.

  • Key Eligibility

    Scheduled for any non-mechanical valve surgery or Open Heart surgery where access to LAA is expected